MANA Advisors’s Pfizer PFE Stock Holding History

MANA Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-14,822	Closed	-$505K	–	158
2019 Q3	$505K	Buy	+14,822	New	+$539K	2.14%	3
2019 Q2	–	Sell	-5,702	Closed	-$230K	–	211
2019 Q1	$230K	Buy	+5,702	New	+$228K	0.75%	75
2018 Q3	–	Sell	-6,123	Closed	-$211K	–	115
2018 Q2	$211K	Sell	6,123 -3,709	-38%	-$127K	1.13%	45
2018 Q1	$331K	Buy	+9,832	New	+$338K	0.48%	95

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

MANA Advisors's PFE Position: Q4 2019 in Review

MANA Advisors sold out of Pfizer (PFE) in Q4 2019, closing a stake of 14,822 shares — an estimated $505K sold.

MANA Advisors first reported a position in PFE in Q1 2018 and held it in 4 quarters. The position peaked at $505K in Q3 2019. 2,524 funds tracked by Wall St. Rank hold PFE as of Q4 2019.

MANA Advisors reported no remaining Pfizer position as of Q4 2019 after selling out during the quarter.
MANA Advisors sold 14,822 Pfizer shares in Q4 2019, an estimated $505K.
MANA Advisors first reported a position in Pfizer in Q1 2018 and held it in 4 quarters.
MANA Advisors's Pfizer position peaked at $505K in Q3 2019.
2,524 funds tracked by Wall St. Rank held Pfizer as of Q4 2019.

Based on MANA Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.